Option chain shows key data for Mangoceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Mangoceuticals.

Mangoceuticals (NASDAQ:MGRX) Stock, Option Chain

Mangoceuticals

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

xr:d:DAE9HpS4rJc:9180,j:2728248388,t:23041414

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

COTY

MGRX

XXII

Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter

Screenshot 2024-09-25 at 8.34.28 PM

Health Care

Interview

General

Men&#39;s Telehealth Company&#39;s Plans To Change Men&#39;s Wellness

Screenshot 2024-09-04 at 5.36.44 PM

Biotech

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform

Mangoceuticals Inc

Press Releases

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research

Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution

Mangoceuticals Announces the Launch of "PeachesRx" - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments

Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

UPXI

Guardian Pharmacy Services, Inc. Class A Common Stock

Guardian Pharmacy Service

Ridgetech

Walgreens Boots Alliance, Inc. - Common Stock

Walgreens Boots Alliance

Screenshot 2024-07-24 at 5.47.14 PM

Emerging Markets

This Men&#39;s Telehealth Company Has A Unique Take On Telehealth And Products

Screenshot 2024-07-17 at 5.41.58 PM

Say Goodbye To Inconvenient TRT: Meet The Game-Changing Oral Testosterone Treatment - PRIME By MangoRx

Screenshot 2024-07-09 at 1.59.17 PM

Erectile Function Vs Erectile Dysfunction: How MangoRx&#39;s (NASDAQ: MGRX) Product Sets Itself Apart And Caters To A Large Market (Pun Intended)

Comments

Mangoceuticals

Mangoceuticals (MGRX) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell